MoonLake Immunotherapeutics (MLTX) Depreciation and Depletion (2021 - 2024)
MoonLake Immunotherapeutics' (MLTX) quarterly Depreciation and Depletion came in at $32515.0 in Q3 2024, up 888.3% year-on-year from $3290.0 in Q4 2023, and up 15.66% quarter-over-quarter from $28112.0 in Q2 2024.
MoonLake Immunotherapeutics (MLTX) Depreciation and Depletion (2021 - 2024) Analysis & Trends
MoonLake Immunotherapeutics' Depreciation and Depletion history runs 4 years deep, the most recent figure standing at $32515.0 for Q3 2024.
- On a quarterly basis, Depreciation and Depletion rose 888.3% year-over-year to $32515.0 in Q3 2024; TTM through Sep 2024 was $86729.0, a 559.14% increase from a year earlier, with the FY2023 full-year figure at $13158.0, up 6.47% from the prior year.
- Depreciation and Depletion advanced to $32515.0 in Q3 2024 per MLTX's latest filing, from $28112.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $32515.0 in Q3 2024 and bottomed at $2271.0 in Q3 2021.
- The 4-year median for Depreciation and Depletion is $3290.0 (2023), against an average of $8938.3.
- Across the five-year window, Depreciation and Depletion sank 33.84% in 2022 and surged 888.3% in 2024, its largest moves.
- Year by year, Depreciation and Depletion stood at $4971.0 in 2021, then slumped by 33.84% to $3289.0 in 2022, then changed by 0.0% to $3289.0 in 2023, then surged by 888.6% to $32515.0 in 2024.
- Per Business Quant, the three latest MLTX Depreciation and Depletion figures stand at $32515.0 (Q3 2024), $28112.0 (Q2 2024), and $22813.0 (Q1 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | MoonLake Immunotherapeutics | 1.38 Bn | 1.02 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 32,515.00 |
| Sep 30, 2024 | 32,515.00 |
| Jun 30, 2024 | 28,112.00 |
| Jun 30, 2024 | 28,112.00 |
| Mar 31, 2024 | 22,813.00 |
| Mar 31, 2024 | 22,813.00 |
| Dec 31, 2023 | 3,289.00 |
| Dec 31, 2023 | 3,289.00 |
| Sep 30, 2023 | 3,290.00 |
| Sep 30, 2023 | 3,290.00 |
| Jun 30, 2023 | 3,289.00 |
| Jun 30, 2023 | 3,289.00 |
| Mar 31, 2023 | 3,290.00 |
| Mar 31, 2023 | 3,290.00 |
| Dec 31, 2022 | 3,289.00 |
| Dec 31, 2022 | 3,289.00 |
| Sep 30, 2022 | 3,293.00 |
| Sep 30, 2022 | 3,293.00 |
| Jun 30, 2022 | 3,288.00 |
| Jun 30, 2022 | 3,288.00 |